Видео ютуба по тегу Event: Esmo Breast 2020

ESMO 2020 Expert Video Report on CDK4 6i in the adjuvant treatment of breast cancer
ESMO 2020 Expert Video Report on CDK4 6i in the adjuvant treatment of breast cancer
Breast Cancer ESMO 2025 Highlights: MonarchE, NATALEE, VIKTORIA1, evERA, DESTINY, ASCENT, TROPION
Breast Cancer ESMO 2025 Highlights: MonarchE, NATALEE, VIKTORIA1, evERA, DESTINY, ASCENT, TROPION
UCSF Bay Area Breast Cancer Forum: Updates from ESMO 2020 2020: New Developments in Treatment
UCSF Bay Area Breast Cancer Forum: Updates from ESMO 2020 2020: New Developments in Treatment
How to Make Sense of Breast Cancer Data from ESMO 2025
How to Make Sense of Breast Cancer Data from ESMO 2025
ESMO 2020 Highlights on neoadjuvant ICI in early TNBC: The IMpassion031 study
ESMO 2020 Highlights on neoadjuvant ICI in early TNBC: The IMpassion031 study
Breast cancer at ESMO 2020: IMpassion131, SOLAR-1, PALLAS and more
Breast cancer at ESMO 2020: IMpassion131, SOLAR-1, PALLAS and more
ESMO 2020 Highlights on alpelisib plus fulvestrant for HR+/HER2– ABC: The SOLAR-1 study
ESMO 2020 Highlights on alpelisib plus fulvestrant for HR+/HER2– ABC: The SOLAR-1 study
ESMO Breast 2021 highlights
ESMO Breast 2021 highlights
Critical Review of ESMO 2025 in Breast Cancer Treatment Approach
Critical Review of ESMO 2025 in Breast Cancer Treatment Approach
Breast cancer at ESMO 2020: CDK4/6 inhibitors and checkpoint inhibitors
Breast cancer at ESMO 2020: CDK4/6 inhibitors and checkpoint inhibitors
ESMO Daily Reporter Talk: The role of CDK4/6 inhibitors in the early stage of #breastcancer.
ESMO Daily Reporter Talk: The role of CDK4/6 inhibitors in the early stage of #breastcancer.
Breast cancer roundup from ESMO 2020
Breast cancer roundup from ESMO 2020
Breast cancer highlights from ESMO 2025
Breast cancer highlights from ESMO 2025
Highlights from ESMO Breast 2021
Highlights from ESMO Breast 2021
ESMO Breast Cancer 2026 - Call for abstracts
ESMO Breast Cancer 2026 - Call for abstracts
Highlights in breast cancer at ESMO 2024: KEYNOTE-522
Highlights in breast cancer at ESMO 2024: KEYNOTE-522
#ESMOBreast24: Reasons to attend this top, international Congress for the breast cancer community
#ESMOBreast24: Reasons to attend this top, international Congress for the breast cancer community
ESO-ESMO-ABC guidelines in metastatic breast cancer
ESO-ESMO-ABC guidelines in metastatic breast cancer
Key lectures from ESMO Breast Cancer 2022
Key lectures from ESMO Breast Cancer 2022